ANI Pharmaceuticals (id:6506 ANIP)
55.83 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/21/2024 6:38:45 PM)
Exchange closed, opens in 14 hours 51 minutes
0.41 USD (0.41%)
-5.37 USD (-5.37%)
-2.38 USD (-2.38%)
-9.54 USD (-9.54%)
8.07 USD (8.07%)
-3.37 USD (-3.37%)
1.42 USD (1.42%)
-84.34 USD (-84.34%)
About ANI Pharmaceuticals
Market Capitalization 1.16B
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
| Headquarters (address) |
210 Main Street West Baudette 56623 MN United States |
| Phone | 218 634 3500 |
| Website | https://www.anipharmaceuticals.com |
| Employees | 642 |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty & Generic |
| Ticker | ANIP |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 48.20 - 70.81 |
| Market Capitalization | 1.16B |
| P/E trailing | 51.63 |
| P/E forward | 9.99 |
| Price/Sale | 2.09 |
| Price/Book | 2.66 |
| Beta | 0.710 |
| EPS | -0.470 |
| EPS United States (ID:6, base:3394) | 24.31 |